All Studies Meta Analysis Recent:

Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports

Enyeji et al., Viral Immunology, doi:10.1089/vim.2024.0034

Aug 2024

Post
Facebook

Source PDF All Studies Meta AnalysisMeta

Famotidine for COVID-19

26th treatment shown to reduce risk in October 2021

^*, now with p = 0.00028 from 30 studies, recognized in 2 countries.

Lower risk for mortality, hospitalization, recovery, and viral clearance.

No treatment is 100% effective. Protocols combine treatments. ^* >10% efficacy, ≥3 studies.

4,700+ studies for 94 treatments. c19early.org

Review of the successful treatment of COVID-19 using existing medications including HCQ, AZ, ivermectin, famotidine, monoclonal antibodies, and others. Authors note that the typical treatment of severe viral infections with multiple therapeutic agents has generally not been done in COVID-19 clinical trials, that different mechanisms of action from multiple treatments can minimize the emergence of drug-resistant SARS-CoV-2 strains, and that early treatment disrupts viral replication, avoids progression to cytokine storm, and is critical to avoid long-term complications.

Important missing comments or errors? Let us know.

Review covers ivermectin, HCQ, famotidine, bebtelovimab, tixagevimab/cilgavimab, and sotrovimab.

Enyeji et al., 5 Aug 2024, peer-reviewed, 3 authors.

This Paper Famotidine All

{ 'indexed': {'date-parts': [[2024, 8, 6]], 'date-time': '2024-08-06T00:25:30Z', 'timestamp': 1722903930363}, 'reference-count': 14, 'publisher': 'Mary Ann Liebert Inc', 'license': [ { 'start': { 'date-parts': [[2024, 8, 5]], 'date-time': '2024-08-05T00:00:00Z', 'timestamp': 1722816000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/'}], 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.1089/vim.2024.0034', 'type': 'journal-article', 'created': {'date-parts': [[2024, 8, 3]], 'date-time': '2024-08-03T11:03:52Z', 'timestamp': 1722683032000}, 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Effective Treatment of COVID-19 Infection with Repurposed Drugs: Case Reports', 'prefix': '10.1089', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-2653-8605', 'authenticated-orcid': False, 'given': 'Abraham M.', 'family': 'Enyeji', 'sequence': 'first', 'affiliation': [ { 'name': 'Division of Community Medicine, Mercer University School of ' 'Medicine, Columbus, Georgia, 31901, USA.'}]}, { 'given': 'Amit', 'family': 'Arora', 'sequence': 'additional', 'affiliation': [ { 'name': 'Georgetown University, Data Science and Analytics Washington, DC ' '20057, USA.'}]}, { 'given': 'Harpal S.', 'family': 'Mangat', 'sequence': 'additional', 'affiliation': [ { 'name': 'Germantown Medical Health Center, Germantown, Maryland, 20876 ' 'USA.'}]}], 'member': '278', 'published-online': {'date-parts': [[2024, 8, 5]]}, 'reference': [ {'key': 'B1', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/978-3-030-88863-3_14'}, {'key': 'B2', 'doi-asserted-by': 'publisher', 'DOI': '10.13016/i1wo-er4h'}, {'key': 'B4', 'doi-asserted-by': 'publisher', 'DOI': '10.1093/cid/ciac663'}, {'key': 'B5', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.rce.2020.05.006'}, {'key': 'B6', 'doi-asserted-by': 'publisher', 'DOI': '10.1001/jamaoto.2020.1922'}, {'key': 'B7', 'doi-asserted-by': 'publisher', 'DOI': '10.7554/eLife.59177'}, {'key': 'B8', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms22115438'}, { 'issue': '2', 'key': 'B9', 'first-page': '1088', 'volume': '17', 'author': 'Mangat HS', 'year': '2023', 'journal-title': 'Health Sci J'}, { 'key': 'B10', 'doi-asserted-by': 'publisher', 'DOI': '10.29121/granthaalayah.v8.i7.2020.678'}, {'key': 'B11', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jinf.2020.07.005'}, {'key': 'B12', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/head.14006'}, {'key': 'B13', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.envres.2020.109754'}, {'key': 'B14', 'doi-asserted-by': 'publisher', 'DOI': '10.34172/jrip.2020.19'}, {'key': 'B15', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/SCIADV.ABD4049'}], 'container-title': 'Viral Immunology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://www.liebertpub.com/doi/full-xml/10.1089/vim.2024.0034', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://www.liebertpub.com/doi/pdf/10.1089/vim.2024.0034', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 8, 5]], 'date-time': '2024-08-05T14:00:56Z', 'timestamp': 1722866456000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.liebertpub.com/doi/10.1089/vim.2024.0034'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 8, 5]]}, 'references-count': 14, 'alternative-id': ['10.1089/vim.2024.0034'], 'URL': 'http://dx.doi.org/10.1089/vim.2024.0034', 'relation': {}, 'ISSN': ['0882-8245', '1557-8976'], 'subject': [], 'container-title-short': 'Viral Immunology', 'published': {'date-parts': [[2024, 8, 5]]}}

Download Image

Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

Post

@CovidAnalysis

FAQ

Public domain CC0 1.0